Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
DiNAQOR cooperating with research institute in Australia
Schlieren ZH/Westmead - Genetic company DiNAQOR and the Children’s Medical Research Institute in Australia are joining forces to research novel cardiac-specific capsid variants. This enables gene therapies to be routed directly to the cardiac muscle.
R&M to acquire the Italian firm Tecnosteel
Wetzikon ZH/Brunello - Reichle & De-Massari (R&M) has agreed a deal to acquire Tecnosteel, the Italian manufacturer of racks and enclosures for data centers. With this takeover, the cabling specialist from the Greater Zurich Area is aiming to offer infrastructure solutions for data centers from a single source in future.
Xlife Sciences set to switch to SIX Swiss Exchange
Zurich - Xlife Sciences has drawn up plans for a listing in the new “Sparks” segment of the SIX Swiss Exchange for SMEs in the first quarter of 2022. At present, the company with a focus on the further development of promising life sciences technologies is listed on the Munich Stock Exchange.
Authorization for ensovibep imminent following Phase 2 study data
Schlieren ZH - The efficacy of ensovibep, a COVID-19 drug developed by Molecular Partners, has been confirmed as part of a Phase 2 study. Novartis will now seek to secure exclusive licensing rights. Molecular Partners will receive a one-off payment of 150 million Swiss francs and retain royalty rights of 22 percent of ensovibep sales.
Start-ups raise record levels of capital in 2021
Amsterdam - Swiss start-ups banked a total of 3.1 billion US dollars in venture capital from investors last year. As such, the total value of the Swiss start-up ecosystem has increased by a factor of 3.7 since 2016. Moreover, Switzerland yields more start-ups per capita than its neighboring countries.
Neurimmune announces link-up with AstraZeneca
Schlieren ZH - Neurimmune has entered into a collaboration and license agreement with the AstraZeneca subsidiary Alexion for the development and marketing of the cardiovascular medication NI006. Neuroimmune will receive an upfront payment of 30 million US dollars with the potential for additional payments contingent on the achievement of milestones of up to 730 million US dollars.
Ferrari cooperating with Greater Zurich blockchain firm
Zug/Maranello - Ferrari is joining forces with the Zug-based start-up Velas Network. As part of this link-up, Velas Network will develop digital content on the basis of blockchain technology for the luxury Italian automotive manufacturer. This content is intended to appeal to fans of the Scuderia motorsport division.
Investors give Sygnum 90 million US dollars
Zurich - Sygnum has secured 90 million US dollars in an oversubscribed series B funding round. The digital asset specialist with a Swiss banking license and portfolio management license in Singapore plans to use this to invest in new products and expand into new markets.
Energy Vault accelerates global scale-up
Lugano/Seoul - Korea Zinc and its Australian subsidiary Sun Metals plan to produce green zinc using Energy Vault’s energy storage plants. Additionally, Korea Zinc is investing 50 million US dollars in the merger of Energy Vault and Novus Capital Corporation II.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space